Braunstein Scott
Transaction: 03/03/2026
SELL
Change
-25,000
Price
$7.44
Filing
03/05/2026
Type
SELL
RAPT Therapeutics, Inc.
RAPT • Biotechnology
$58.01
▲ +0.00 (+0.00%)
Current price
EarningsLatest report: Sep 30, 2025
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.56B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.02Healthy liquidity · 4.87Negative growth trendWeak profitability
Financial data as of: Sep 30, 2025, 12:00 AM UTCLast earnings update: Nov 6, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$58.01
Change0.00%
Shares Out26.96M
Market Cap$1.56B
Enterprise Value$1.41B
52W Range5.67 - 58.02
Beta0.44
P/E-14.81
P/B10.29
P/FCF-18.05
EV/EBITDA-13.05
EV/FCF-16.26
Price$58.01
Change0.00%
Shares Out26.96M
Market Cap$1.56B
Enterprise Value$1.41B
52W Range5.67 - 58.02
Beta0.44
P/E-14.81
P/B10.29
P/FCF-18.05
EV/EBITDA-13.05
EV/FCF-16.26
Earnings Yield-6.75%
FCF Yield-5.54%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.02
Current Ratio4.87
Quick Ratio4.87
Target$44.60
Target Upside-23.11%
Target Median$58.00
Target Range2.00 - 70.00
Volume10.85M
Avg Volume2.34M
EPS Surprise-8.30
Investment DNA
How strong this company looks for long-term investors
42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.02Healthy liquidity · 4.87Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 15 analyst votes · 2026-09-05
63/100
Neutral
Bullish
4
Hold
11
Bearish
0
Price Target
2026-06-06
Low
$58.00
Mean
$58.00
Median
$58.00
High
$58.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Braunstein Scott
Transaction: 03/03/2026
SELL
Change
-4,956
Price
Not reported
Filing
03/05/2026
Type
SELL
Kozick Linda
Transaction: 03/03/2026
SELL
Change
-32,229
Price
$7.44
Filing
03/05/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Braunstein Scott | SELL | -25,000 | $7.44 | 03/03/2026 | 03/05/2026 |
| Braunstein Scott | SELL | -4,956 | Not reported | 03/03/2026 | 03/05/2026 |
| Kozick Linda | SELL | -32,229 | $7.44 | 03/03/2026 | 03/05/2026 |
| Kozick Linda | SELL | -4,956 | Not reported | 03/03/2026 | 03/05/2026 |
| Wong Brian Russell | SELL | -64,102 | Not reported | 03/03/2026 | 03/05/2026 |
| Wong Brian Russell | SELL | -218,250 | $9.12 | 03/03/2026 | 03/05/2026 |
| Brockstedt Dirk G. | SELL | -4,648 | Not reported | 03/03/2026 | 03/05/2026 |
| Brockstedt Dirk G. | SELL | -64,375 | $9.12 | 03/03/2026 | 03/05/2026 |
| Young Rodney KB | SELL | -3,304 | Not reported | 03/03/2026 | 03/05/2026 |
| Young Rodney KB | SELL | -80,250 | $9.12 | 03/03/2026 | 03/05/2026 |
| Dombkowski Ashley L. | SELL | -25,000 | $7.44 | 03/03/2026 | 03/05/2026 |
| Dombkowski Ashley L. | SELL | -4,956 | Not reported | 03/03/2026 | 03/05/2026 |
| Giordano Michael F | SELL | -32,229 | $7.44 | 03/03/2026 | 03/05/2026 |
| Giordano Michael F | SELL | -4,956 | Not reported | 03/03/2026 | 03/05/2026 |
| GRAY MARY ANN | SELL | -32,229 | $7.44 | 03/03/2026 | 03/05/2026 |
| GRAY MARY ANN | SELL | -4,956 | Not reported | 03/03/2026 | 03/05/2026 |
| Lyons-Williams Lori | SELL | -32,229 | $7.44 | 03/03/2026 | 03/05/2026 |
| Lyons-Williams Lori | SELL | -4,956 | Not reported | 03/03/2026 | 03/05/2026 |
| Dombkowski Ashley L. | BUY | +4,956 | Not reported | 01/30/2026 | 02/02/2026 |
| Kozick Linda | BUY | +4,956 | Not reported | 01/30/2026 | 02/02/2026 |